We use cookies on your browser to customize content for your viewing and for analytics. If you click “Accept” or continue to browse our website, we assume you have agreed to our use of cookies. For details, please refer to our Cookies Policy.
26 August
144
Pulnovo Medical, a globally recognized device pioneer in the treatment for pulmonary hypertension and heart failure, has recently announced a strategic partnership with Nanjing Medical University (NMU). This partnership is aligned with the national strategy of integrating education with industry, aiming to bridge the gaps between educational talent and industrial expertise. It promotes the integration of research outcomes with technological advancements, and fosters high-quality development.
The signing ceremony, which took place at Pulnovo Medical's Innovative Center on 21st August, marked the beginning of this innovative collaboration. The event included the formal signing of the partnership agreement, the unveiling of a new collaboration base, and the initiation of research projects. These initiatives establish a robust platform for pioneering cardiovascular research and its clinical applications.
During the event, key stakeholders expressed their insights and high expectations for the partnership. They emphasized the importance of this collaboration in advancing China’s medical technology sector, highlighting its role as a model of how academic institutions and industry can work together to transform research into real-world medical solutions. Pulnovo Medical affirmed its commitment to leveraging this partnership to enhance cardiovascular disease prevention and treatment, both domestically and globally. The partnership is seen as a perfect fusion of innovation and practical application, setting the stage for significant breakthroughs in medical technology.
This strategic partnership represents a significant exploration of new collaboration models and a breakthrough in cardiovascular research. NMU and Pulnovo Medical are committed to advancing medical technology and building an ecosystem of Industry-University-Research collaboration, ultimately benefiting patients worldwide.
About Pulnovo Medical
Pulnovo Medical Limited, is a globally recognized device pioneer in the treatment for pulmonary hypertension and heart failure. Established in 2013 and rooted in innovation, Pulnovo Medical is committed to leveraging our deep expertise in the science of breakthrough technologies with the goal to market our innovative therapeutic solutions and benefit patients around the world.